254 related articles for article (PubMed ID: 37152961)
21. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
[TBL] [Abstract][Full Text] [Related]
22. New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma.
Taïeb D; Pacak K
Trends Endocrinol Metab; 2017 Nov; 28(11):807-817. PubMed ID: 28867159
[TBL] [Abstract][Full Text] [Related]
23. Composite paraganglioma-ganglioneuroma with atypical catecholamine profile and phenylethanolamine N-methyltransferase expression: a case report and literature review.
Sasaki Y; Kanzawa M; Yamamoto M; Kanie K; Bando H; Yoshino K; Hirota Y; Shigemura K; Fujisawa M; Ogawa W; Fukuoka H
Endocr J; 2024 Jan; 71(1):65-74. PubMed ID: 37952980
[TBL] [Abstract][Full Text] [Related]
24. Pheochromocytomas and Paragangliomas.
Tevosian SG; Ghayee HK
Endocrinol Metab Clin North Am; 2019 Dec; 48(4):727-750. PubMed ID: 31655773
[TBL] [Abstract][Full Text] [Related]
25. [Phaeochromocytoma and paraganglioma].
Cornu E; Belmihoub I; Burnichon N; Grataloup C; Zinzindohoué F; Baron S; Billaud E; Azizi M; Gimenez-Roqueplo AP; Amar L
Rev Med Interne; 2019 Nov; 40(11):733-741. PubMed ID: 31493938
[TBL] [Abstract][Full Text] [Related]
26. Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?
Fishbein L
Curr Cardiol Rep; 2019 Jul; 21(9):104. PubMed ID: 31367972
[TBL] [Abstract][Full Text] [Related]
27. [Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines].
Liu L; Tian J; Wu K; Gao Y; Zhang Z; Zhang JQ; Guo XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):614-620. PubMed ID: 32773788
[TBL] [Abstract][Full Text] [Related]
28. Germline DLST Variants Promote Epigenetic Modifications in Pheochromocytoma-Paraganglioma.
Buffet A; Zhang J; Rebel H; Corssmit EPM; Jansen JC; Hensen EF; Bovée JVMG; Morini A; Gimenez-Roqueplo AP; Hes FJ; Devilee P; Favier J; Bayley JP
J Clin Endocrinol Metab; 2021 Jan; 106(2):459-471. PubMed ID: 33180916
[TBL] [Abstract][Full Text] [Related]
29. Approach to the Patient: Perioperative Management of the Patient with Pheochromocytoma or Sympathetic Paraganglioma.
Berends AMA; Kerstens MN; Lenders JWM; Timmers HJLM
J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32726444
[TBL] [Abstract][Full Text] [Related]
30. [Diagnostic approach of pheochromocytomas and paragangliomas].
Gómez RM; Hernaiz M; de Miguel V; Aparicio LS; Marín MJ; Lupi S; Barontini M;
Hipertens Riesgo Vasc; 2019; 36(1):34-43. PubMed ID: 30078655
[TBL] [Abstract][Full Text] [Related]
31. Pheochromocytoma/Paraganglioma: A Poster Child for Cancer Metabolism.
Tevosian SG; Ghayee HK
J Clin Endocrinol Metab; 2018 May; 103(5):1779-1789. PubMed ID: 29409060
[TBL] [Abstract][Full Text] [Related]
32. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K
J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990
[TBL] [Abstract][Full Text] [Related]
33. Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry.
Juhlin CC
Endocr Pathol; 2021 Jun; 32(2):228-244. PubMed ID: 33768452
[TBL] [Abstract][Full Text] [Related]
34. Rethinking pheochromocytomas and paragangliomas from a genomic perspective.
Castro-Vega LJ; Lepoutre-Lussey C; Gimenez-Roqueplo AP; Favier J
Oncogene; 2016 Mar; 35(9):1080-9. PubMed ID: 26028031
[TBL] [Abstract][Full Text] [Related]
35. Pheochromocytomas and secreting paragangliomas.
Plouin PF; Gimenez-Roqueplo AP
Orphanet J Rare Dis; 2006 Dec; 1():49. PubMed ID: 17156452
[TBL] [Abstract][Full Text] [Related]
36. [Personal experience in diagnosis and localization of pheochromocytoma].
Andjelković Z; Tavcar I
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():14-9. PubMed ID: 12584992
[TBL] [Abstract][Full Text] [Related]
37. Retinal arterial remodeling in patients with pheochromocytoma or paraganglioma and its reversibility following surgical treatment.
Gosk-Przybyłek M; Doroszko A; Dobrowolski P; Warchoł-Celińska E; Harazny J; Bińczyk E; Szymanek K; Pęczkowska M; Kabat M; Toutounchi S; Gałązka Z; Górnicka B; Szaflik J; Januszewicz M; Klisiewicz A; Hoffman P; Lenders JWM; Eisenhofer G; Szaflik JP; Schmieder RE; Prejbisz A; Januszewicz A
J Hypertens; 2020 Aug; 38(8):1551-1558. PubMed ID: 32205562
[TBL] [Abstract][Full Text] [Related]
38. Protocol for presurgical and anesthetic management of pheochromocytomas and sympathetic paragangliomas: a multidisciplinary approach.
Araujo-Castro M; Pascual-Corrales E; Nattero Chavez L; Martínez Lorca A; Alonso-Gordoa T; Molina-Cerrillo J; Lorca Álvaro J; Mínguez Ojeda C; Redondo López S; Barberá Durbán R; Polo López R; Moreno Mata N; Caballero Silva U; Pian H; Ruz-Caracuel I; Sanjuanbenito Dehesa A; Gómez Dos Santos V; Serrano Romero AB
J Endocrinol Invest; 2021 Dec; 44(12):2545-2555. PubMed ID: 34304388
[TBL] [Abstract][Full Text] [Related]
39. Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems.
Wachtel H; Hutchens T; Baraban E; Schwartz LE; Montone K; Baloch Z; LiVolsi V; Krumeich L; Fraker DL; Nathanson KL; Cohen DL; Fishbein L
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4661-70. PubMed ID: 32877928
[TBL] [Abstract][Full Text] [Related]
40. Pheochromocytoma: a review.
Tsirlin A; Oo Y; Sharma R; Kansara A; Gliwa A; Banerji MA
Maturitas; 2014 Mar; 77(3):229-38. PubMed ID: 24472290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
